SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Glenmark Generics receives USFDA nod for desogestrel & ethinyl estradiol tablets

03 Apr 2012 Evaluate

Glenmark Generics Incorporation, USA, a subsidiary of Glenmark Generics, has been granted final abbreviated new drug approval (ANDA) from the United States Food and Drug Administration (USFDA) for Desogestrel and Ethinyl Estradiol Tablets USP, 0.15mg/0.02 mg and Ethinyl Estradiol Tablets USP 0.01mg. The company will market its product as Viorele tablets and plan to commence shipping immediately.

Viorele tablets are Glenmark’s generic version of Mircette tablets by Teva Women’s Health Inc. Viorele is indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception.

Glenmark’s current portfolio consists of 78 products authorized for distribution in the US marketplace and 40 ANDA's pending approval with the USFDA.

Glenmark Generics Incorporation (GGI), USA is the North American division of Glenmark Generics dedicated to the manufacture, marketing and distribution of generic pharmaceutical products. GGI (formerly Glenmark Pharmaceuticals Incorporation, USA) established operations in 2003 and was a subsidiary of Glenmark Pharmaceuticals.

Glenmark Pharma Share Price

2364.35 -6.70 (-0.28%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×